Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors.
Annals of Oncology.
Times cited: 58
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
Journal of Medical Genetics.
Times cited: 55